Suicide | Veterans Coping Long-term With Active Suicide
Suicide research study
What is the primary objective of this study?
The proposed study seeks to test the efficacy of an intervention to reduce suicide behaviors in Veterans. The Veterans Coping Long Term with Active Suicide Program (CLASP-VA) is an innovative, telephone-based intervention that combines elements of individual therapy, case management, and significant other/family therapy and is designed to be integrated into a VA system.
Who is eligible to participate?
Inclusion Criteria: - suicide attempt or suicidal ideation with any methods, plan, and/or intent to make a suicide attempt within 1 week of hospitalization - age greater than 18 - have a telephone - ability to speak, read, and understand spoken English sufficiently well to complete the procedures of the study Exclusion Criteria: - long-term psychiatric disorder - diagnosis of borderline personality disorder - cognitive impairment which would interfere with adequate participation in the project (MMSE <20)
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Behavioral:Coping Long Term with Active Suicidean intervention to reduce suicide behavior in Veterans recently hospitalized for suicide attempt or ideation with intent.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
CLASP InterventionA 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.
Safety Assessment and follow up EvaluationTreatment as usual plus enhanced monitoring.
Active, not recruiting
Start Date: February 24, 2014
Completed Date: August 31, 2018
Primary Outcome: Changes in Columbia Suicide Severity Rating Scale (C-SSRS)
Secondary Outcome: Changes in Beck Hopelessness Scale
Study sponsors, principal investigator, and references
Principal Investigator: Jennifer Marie Primack, PhD MA
Lead Sponsor: VA Office of Research and Development
Collaborator: Butler Hospital